Concepedia

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial

Shengyuan Yu, Byung‐Kun Kim, Aihong Guo, Manho Kim, Mingjie Zhang, Zhen Wang, Jianguang Liu, Heui‐Soo Moon, Ge Tan, Qian Yang,

The Lancet Neurology · 2023 · 70 citations · 17 references

DOI

Concepts

References

17

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Theo Vos, Stephen S Lim, Cristiana Abbafati et al. · The Lancet · 2020 · 19.2K citations · Full text

, , +16

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Cephalalgia · 2018 · 10.5K citations · Full text

, , +6

The International Classification of Headache Disorders, 3rd edition (beta version)

Cephalalgia · 2013 · 8.2K citations · Full text

, , +14

EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force

Stefan Evers, Judit Áfra, Achim Frese et al. · European Journal of Neurology · 2009 · 894 citations · Full text

, , +15

Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine

Richard B. Lipton, Robert Croop, Elyse Stock et al. · New England Journal of Medicine · 2019 · 396 citations · Full text

, , +14